methylene blue has been researched along with Parasitemia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Briolant, S; Desgrouas, C; Dormoi, J; Pradines, B | 1 |
| Kiboi, DM; Mumo, RM; Mwangi, VI; Ng'ang'a, ZW; Omar, SA; Ozwara, HS | 1 |
| Arora, K; Srivastava, AK | 1 |
| Bueno, JL; Carrión, J; Castro, E; Fresno, M; Gironés, N | 1 |
4 other study(ies) available for methylene blue and Parasitemia
| Article | Year |
|---|---|
Impact of methylene blue and atorvastatin combination therapy on the apparition of cerebral malaria in a murine model.
Topics: Animals; Antimalarials; Atorvastatin; Disease Models, Animal; Drug Synergism; Female; Heptanoic Acids; Kaplan-Meier Estimate; Malaria, Cerebral; Methylene Blue; Mice; Mice, Inbred C57BL; Parasitemia; Pyrroles | 2013 |
Methylene blue inhibits lumefantrine-resistant Plasmodium berghei.
Topics: Animals; Antimalarials; Disease Models, Animal; Drug Resistance; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Ethanolamines; Female; Fluorenes; Lumefantrine; Malaria; Male; Methylene Blue; Mice; Parasitemia; Plasmodium berghei; Pyrimethamine; Survival Analysis; Treatment Outcome | 2016 |
Antimalarial efficacy of methylene blue and menadione and their effect on glutathione metabolism of Plasmodium yoelii-infected albino mice.
Topics: Administration, Oral; Animals; Antifibrinolytic Agents; Drug Evaluation, Preclinical; Enzyme Inhibitors; Glutathione; Liver; Malaria; Methylene Blue; Mice; Parasitemia; Plasmodium yoelii; Spleen; Suspensions; Vitamin K 3 | 2005 |
The efficacy of photochemical treatment with methylene blue and light for the reduction of Trypanosoma cruzi in infected plasma.
Topics: Animals; Chagas Disease; Interferon-gamma; Light; Methylene Blue; Mice; Mice, Knockout; Nitric Oxide Synthase Type II; Parasitemia; Photochemotherapy; Plasma; Survival Rate; Trypanocidal Agents; Trypanosoma cruzi | 2006 |